|Articles|October 1, 1998

Clinical and Economic Considerations of Antimicrobial Use
Volume 4
Issue 11 Suppl

Pharmacoeconomic Impact of Appropriate Clinical Pathways

Author(s)N. Stephen Ober, MD

Download PDF: Pharmacoeconomic Impact of Appropriate Clinical Pathways

Articles in this issue

over 27 years ago

Article

Optimizing Antimicrobial Therapy and Emerging Pathogens

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

Introduction

over 27 years ago

Article

Mechanisms and Current Rates of Resistance

over 27 years ago

Article

Influence of Antibiotics on the Normal Flora

over 27 years ago

Article

Therapeutic Pathways for Antimicrobial Use: General Overview

over 27 years ago

Article

Therapeutic Pathways for Antimicrobial Use: Pediatric Issues

over 27 years ago

Article

Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection: Results of a Randomized, Multicenter Study

over 27 years ago

Article

Developing Cost-Effective Guidelines for the Appropriate Use of Antimicrobial Therapy in Respiratory Tract Infection

over 27 years ago

Article

CME Quiz

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Pharmacoeconomic Impact of Appropriate Clinical Pathways

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

Prior Authorization Ranked Top Barrier to Health Care Access After Cost

Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024

Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM

FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film

Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL